Thu.Nov 23, 2023

article thumbnail

Surge of respiratory disease in China triggers anxiety, but experts see likely explanation

STAT

Reports of increased respiratory disease among children in China have put disease watchers elsewhere on alert, triggering anxiety that the outbreak — if it is indeed one outbreak — holds uncomfortable echoes of the start of the Covid-19 pandemic. But at present, a number of experts say the activity has a likely explanation: China’s population, especially its young children, probably developed significant immunological susceptibility to a range of respiratory pathogens d

358
358
article thumbnail

Pharmacy closures rising amid workforce and funding gaps, CCA finds

The Pharmacist

The number of community pharmacies in England is down by 1,008 compared with 2015, according to a new report from the Company Chemists’ Association (CCA). The CCA also found that the rate of net closures is increasing, with an average loss of eight pharmacies per week. More than a third (37.5%) of the net closures […] The post Pharmacy closures rising amid workforce and funding gaps, CCA finds appeared first on The Pharmacist.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Genentech and NVIDIA enter into strategic AI research collaboration

Pharma Times

Both companies will use their platforms to accelerate drug discovery and development - News - PharmaTimes

130
130
article thumbnail

LloydsPharmacy owner completes sale of all high street branches

The Pharmacist

Hallo Healthcare Group has sold all of its 1,054 high street and community pharmacies that operated under the LloydsPharmacy brand, the company has confirmed. The move completes the withdrawal of the UK’s second largest pharmacy chain from the high street. The divestment will see ‘99% of branches staying open in over 1,000 communities’, according to […] The post LloydsPharmacy owner completes sale of all high street branches appeared first on The Pharmacist.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Bayer invests 130 million EUR in new production facility for innovative parenteral products

World Pharma News

Bayer has added a brand new manufacturing facility to its global supply chain network. The new production plant was inaugurated today at the company's global pharmaceutical headquarters in Berlin, Germany. The facility features state-of-the-art technology, innovative production, and automated processes.

101
101
article thumbnail

Investment in novel therapies key priority to tackle AMR: GlobalData

Express Pharma

World AMR Awareness Week (WAAW)* is observed on 18-24 November every year with the aim of improving awareness and understanding of antimicrobial resistance (AMR) and encouraging best practices for the responsible usage of antimicrobials. This year’s theme “Preventing antimicrobial resistance together” highlights the importance of cross-sectoral collaboration for tackling AMR.

More Trending

article thumbnail

Sanjivani Paranteral, Hindustan Antibiotics partner to manufacture IV formulations and IV Sets

Express Pharma

Sanjivani Paranteral has inked an agreement with Hindustan Antibiotics for the manufacturing of IV formulations and IV Sets. The agreement is backed by a confirmed purchase commitment from Hindustan Antibiotics. The partnership will see the establishment of a manufacturing facility within the premises of Hindustan Antibiotics at Pimpri works, Pune, Maharashtra.

article thumbnail

Minimum wage hike could make pharmacy businesses ‘non-viable’

The Pharmacist

The latest National Minimum Wage (NMW) increases will have a severe knock-on effect for community pharmacies, sector leaders have warned. Earlier this week, the government announced that the National Living Wage (NLW) would rise to £11.44 per hour from next April, from the current rate of £10.42. In addition, the age threshold applied to the […] The post Minimum wage hike could make pharmacy businesses ‘non-viable’ appeared first on The Pharmacist.

article thumbnail

Experts believe gene therapies will disrupt Gaucher disease drug market: GlobalData

Express Pharma

Following the conclusion of International Gaucher Disease Awareness Month, key opinion leaders (KOLs) interviewed by GlobalData believe pipeline gene therapies will significantly impact the Gaucher disease landscape. Gene therapy has the curative potential to provide patients with a healthy GBA1 copy, disrupting the Gaucher drug market. However, much groundwork remains to be covered, says GlobalData.

89
article thumbnail

Oligonucleotide manufacturing centre to open in Scotland

European Pharmaceutical Review

Following the UK government’s recent announcement of a £520 million funding boost for UK manufacturing, a new Oligonucleotide Manufacturing Innovation Centre of Excellence in Scotland will develop innovative and sustainable techniques for these medicines. According to the Centre for Process Innovation (CPI), oligonucleotides therapeutics use short, chemically synthesised fragments of DNA or RNA to modulate protein expression and ultimately treat the underlying cause of disease.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

OPPI organises flagship Annual Summit at Le Méridien, New Delhi 

Express Pharma

The Organisation of Pharmaceutical Producers of India (OPPI) organised its flagship Annual Summit on November 23, 2023 at the Le Méridien, New Delhi. The summit was gathering of policymakers, academicians, industry leaders, innovators, scientists, and media representatives. Under the theme ‘Bharat Ke Liye’, the summit served as a platform to deliberate strategies on the future of healthcare in the country.

86
article thumbnail

Change needed on how community pharmacy is viewed ‘at the top’

The Pharmacist

Action must be taken to change the way community pharmacy is viewed ‘at the top’ of the NHS to ensure improvements for the sector, according to the chief executive of the Association of Independent Multiple Pharmacies (AIMp). Dr Leyla Hannbeck suggested that unless there was ‘cultural change’ within the ‘top line of NHS hierarchy’ it […] The post Change needed on how community pharmacy is viewed ‘at the top’ appeared first on The Pharmacist.

article thumbnail

Boehringer Ingelheim acquires T3 Pharma for $509m

Pharmaceutical Technology

T3 Pharma uses a bacterial secretion system for the delivery of immune-modulating proteins to cancer cells and tumour micro-environments.

article thumbnail

The power of data science platforms to cut through the complexity of modern-day clinical research

pharmaphorum

The power of data science platforms to cut through the complexity of modern-day clinical research Mike.

106
106
article thumbnail

Digitalisation and PAT: current landscape and future trends

European Pharmaceutical Review

Last month at CPHI Barcelona 2023 , EPR interviewed Mohamed Noor, Digitalization Manager at the National Institute for Bioprocessing Research and Training ( NIBRT ). During the conversation, Noor shed light on how digitalisation is impacting the biopharmaceutical industry. Additionally, he explored the trends, challenges and opportunities for process analytical technology (PAT).

69
article thumbnail

AstraZeneca joins KRAS push in cancer with Chinese deal

pharmaphorum

AstraZeneca joins KRAS push in cancer with Chinese deal Phil.

128
128
article thumbnail

Biotech startup Cradle raises $24 million Series A to accelerate AI technology

Outsourcing Pharma

Cradle, the biotech startup using generative AI to help scientists design and engineer proteins, has raised $24 million in Series A funding.

104
104
article thumbnail

How can the value of patient engagement be quantified and measured?

pharmaphorum

How can the value of patient engagement be quantified and measured? Mike.

118
118
article thumbnail

US FDA approves Valneva’s vaccine against chikungunya virus

Pharmaceutical Business Review

Claimed to be the first vaccine against the disease to receive FDA’s marketing approval, IXCHIQ uses Albumedix’ Recombumin. Recombumin is an animal origin-free recombinant human albumin and is included as an excipient in the final formulation of the vaccine. Acting as a logistical enabler, it supports the vaccine’s stability and confers storage and logistical benefits, thereby supporting its distribution across the globe.

article thumbnail

How birth tissue donations are fuelling the cell therapy revolution

pharmaphorum

How birth tissue donations are fuelling the cell therapy revolution Mike.

113
113
article thumbnail

MorphoSys shares phase 3 trial results for pelabresib in myelofibrosis treatment

Pharmafile

MorphoSys has announced topline results from its phase 3 MANIFEST-2 study, which assessed pelabresib, an investigational BET inhibitor, in combination with ruxolitinib, a JAK inhibitor for the treatment of JAK inhibitor-naïve patients with myelofibrosis. The trial met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in the proportion of patients achieving at […] The post MorphoSys shares phase 3 trial results for pelabresib in myelofibro

58
article thumbnail

UK “keeping up momentum” on clinical trials review

pharmaphorum

Lord James O’Shaughnessy has welcomed the UK government’s official response to his review of commercial clinical trials, saying there have been a number of positive developments since it was published in the spring.

71
article thumbnail

Landos Biophama shares results from phase 1b trial for ulcerative colitis treatment

Pharmafile

Landos Biopharma has announced that it has shared safety, tolerability, pharmacokinetics and clinical efficacy results for the NX-13 phase 1b trial for patients with ulcerative colitis (UC), having published this data in the Journal of Crohn’s and Colitis. The trial included 38 patients, with the patients randomised to either receive various doses of the NX-13 […] The post Landos Biophama shares results from phase 1b trial for ulcerative colitis treatment appeared first on Pharmafile.

58
article thumbnail

Exploring the impact of patient flow forecasting on the patient and the HCP

pharmaphorum

Exploring the impact of patient flow forecasting on the patient and the HCP Mike.

105
105
article thumbnail

Flywheel and Microsoft collaborate to unlock powerful data insights in medical imaging

Outsourcing Pharma

Healthcare breakthroughs have long-standing barriers when it comes to unlocking the powerful insights trapped in medical imaging data.

97
article thumbnail

Supercharge your supply chain: Harnessing AI to gain competitive advantage

pharmaphorum

Supercharge your supply chain: Harnessing AI to gain competitive advantage Mike.

99
article thumbnail

Adragos Pharma's Japanese site is 'sweet spot' among acquisitions

Outsourcing Pharma

German CDMO Adragos Pharma has its eye on expansion and is continually branching out into new markets.

98
article thumbnail

Novo Nordisk will invest €2.1bn in French manufacturing site

pharmaphorum

Novo Nordisk will invest €2.1bn in French manufacturing site Phil.

95
article thumbnail

A CPG Leader Controlled Costs in a Key Category With GEP Expertise

Pharma and Life Sciences Blog

A CPG Leader Controlled Costs in a Key Category With GEP Expertise annmarie@AZglo… Thu, 11/23/2023 - 21:34 As a result of changing consumer preferences and industry consolidation, a Fortune 500 CPG company had to adapt to rising demand and fewer suppliers in a key category. The company turned to GEP to help optimize its $14 million egg sourcing category.

52
article thumbnail

InDex craters on phase 3 ulcerative colitis failure

pharmaphorum

InDex craters on phase 3 ulcerative colitis failure Phil.

87
article thumbnail

EirGenix and Sandoz win EU approval for Herceptin biosimilar

Pharmaceutical Technology

EirGenix and Sandoz's biosimilar has been approved for all the indications as the reference biologic, Roche’s Herceptin.

article thumbnail

EMCrit Shadowboxing Case 6 – A Respiratory Case along with Extra Commentary from Mae West

EMCrit Project

A pulm-crit shadowboxing case EMCrit Project by Scott Weingart, MD FCCM.

67
article thumbnail

SK bioscience and Hilleman to develop Ebola-Zaire virus vaccine

Pharmaceutical Technology

SK bioscience has signed an agreement with Hilleman Laboratories Singapore for the co-development of a vaccine against the Zaire Ebola virus.

article thumbnail

Centering Sustainability and Environmental Impact in the Supply Chain

PharmaTech

Chris Spivey, editorial director for Pharmaceutical Technology and Biopharm International, spoke with Concetto Andrea Rizza, Marketing and Communications manager, ICE Pharma, on sustainability and ICE’s green approach at CPhI Barcelona 2023.

article thumbnail

FDA fast tracks Alladapt’s multi-food allergy immunotherapy

Pharmaceutical Technology

The fast track designation for the paediatric multi-food allergy therapy ADP101 was based on the Phase I/II data.

59